These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35843341)

  • 1. Nonclinical safety evaluation of a novel ionizable lipid for mRNA delivery.
    Broudic K; Amberg A; Schaefer M; Spirkl HP; Bernard MC; Desert P
    Toxicol Appl Pharmacol; 2022 Sep; 451():116143. PubMed ID: 35843341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonclinical safety assessment of an mRNA Covid-19 vaccine candidate following repeated administrations and biodistribution.
    Broudic K; Laurent S; Perkov V; Simon C; Garinot M; Truchot N; Latour J; Désert P
    J Appl Toxicol; 2024 Mar; 44(3):371-390. PubMed ID: 37723625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration.
    Carrasco MJ; Alishetty S; Alameh MG; Said H; Wright L; Paige M; Soliman O; Weissman D; Cleveland TE; Grishaev A; Buschmann MD
    Commun Biol; 2021 Aug; 4(1):956. PubMed ID: 34381159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fluorinated ionizable lipid improves the mRNA delivery efficiency of lipid nanoparticles.
    Huo H; Cheng X; Xu J; Lin J; Chen N; Lu X
    J Mater Chem B; 2023 May; 11(19):4171-4180. PubMed ID: 37129135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Ionizable Lipid Nanoparticles for SARS-CoV-2 Omicron mRNA Delivery.
    Long J; Yu C; Zhang H; Cao Y; Sang Y; Lu H; Zhang Z; Wang X; Wang H; Song G; Yang J; Wang S
    Adv Healthc Mater; 2023 May; 12(13):e2202590. PubMed ID: 36716702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
    Wang C; Zhang Y; Dong Y
    Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of formulation and atomization of lipid nanoparticles for the inhalation of mRNA.
    Miao H; Huang K; Li Y; Li R; Zhou X; Shi J; Tong Z; Sun Z; Yu A
    Int J Pharm; 2023 Jun; 640():123050. PubMed ID: 37201764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.
    Zeng Y; Escalona-Rayo O; Knol R; Kros A; Slütter B
    Biomater Sci; 2023 Jan; 11(3):964-974. PubMed ID: 36537916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ionizable Lipids with Triazole Moiety from Click Reaction for LNP-Based mRNA Delivery.
    Wang Y; Si X; Feng Y; Feng D; Xu X; Zhang Y
    Molecules; 2023 May; 28(10):. PubMed ID: 37241787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Combinatorial Library of Lipid Nanoparticles for Cell Type-Specific mRNA Delivery.
    Naidu GS; Yong SB; Ramishetti S; Rampado R; Sharma P; Ezra A; Goldsmith M; Hazan-Halevy I; Chatterjee S; Aitha A; Peer D
    Adv Sci (Weinh); 2023 Jul; 10(19):e2301929. PubMed ID: 37092557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unsaturated, Trialkyl Ionizable Lipids are Versatile Lipid-Nanoparticle Components for Therapeutic and Vaccine Applications.
    Lam K; Leung A; Martin A; Wood M; Schreiner P; Palmer L; Daly O; Zhao W; McClintock K; Heyes J
    Adv Mater; 2023 Apr; 35(15):e2209624. PubMed ID: 36680477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iterative Design of Ionizable Lipids for Intramuscular mRNA Delivery.
    Tilstra G; Couture-Senécal J; Lau YMA; Manning AM; Wong DSM; Janaeska WW; Wuraola TA; Pang J; Khan OF
    J Am Chem Soc; 2023 Feb; 145(4):2294-2304. PubMed ID: 36652629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lipid nanoparticle platform incorporating trehalose glycolipid for exceptional mRNA vaccine safety.
    Bae SH; Yoo S; Lee J; Park HJ; Kwon SP; Jin H; Park SI; Lee YS; Bang YJ; Roh G; Lee S; Youn SB; Kim IW; Oh HR; El-Damasy AK; Keum G; Kim H; Youn H; Nam JH; Bang EK
    Bioact Mater; 2024 Aug; 38():486-498. PubMed ID: 38779592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Payload distribution and capacity of mRNA lipid nanoparticles.
    Li S; Hu Y; Li A; Lin J; Hsieh K; Schneiderman Z; Zhang P; Zhu Y; Qiu C; Kokkoli E; Wang TH; Mao HQ
    Nat Commun; 2022 Sep; 13(1):5561. PubMed ID: 36151112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection.
    Lou G; Anderluzzi G; Schmidt ST; Woods S; Gallorini S; Brazzoli M; Giusti F; Ferlenghi I; Johnson RN; Roberts CW; O'Hagan DT; Baudner BC; Perrie Y
    J Control Release; 2020 Sep; 325():370-379. PubMed ID: 32619745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful batch and continuous lyophilization of mRNA LNP formulations depend on cryoprotectants and ionizable lipids.
    Lamoot A; Lammens J; De Lombaerde E; Zhong Z; Gontsarik M; Chen Y; De Beer TRM; De Geest BG
    Biomater Sci; 2023 Jun; 11(12):4327-4334. PubMed ID: 37073472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding structure activity relationships of Good HEPES lipids for lipid nanoparticle mRNA vaccine applications.
    Goldman RL; Vittala Murthy NT; Northen TP; Balakrishnan A; Chivukula S; Danz H; Tibbitts T; Dias A; Vargas J; Cooper D; Gopani H; Beaulieu A; Kalnin KV; Plitnik T; Karmakar S; Dasari R; Landis R; Karve S; DeRosa F
    Biomaterials; 2023 Oct; 301():122243. PubMed ID: 37480759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and applications of mRNA treatment based on lipid nanoparticles.
    Wang Z; Ma W; Fu X; Qi Y; Zhao Y; Zhang S
    Biotechnol Adv; 2023; 65():108130. PubMed ID: 36933868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.